How to Succeed with Facility Capital Investments in China (Session 102)

Sunday 6 November 13.00 – 17.00

ISPE CEUs: 0.35

The pharmaceutical industry is building fewer facilities in the traditional locations of North and Central America, Europe and Singapore. Instead it is moving to newer locations such as China. Project team members from outside China may have many years of experience in project management practice, but coming to China presents them with a range of new cultural, organizational, regulatory and even meteorological challenges to deal with during the execution of their project. Whether working for a large or small pharmaceutical firm, generic manufacturer or contract manufacturer, building an office, warehouse, R&D facility, a bulk API plant, or a pharmaceutical facility, the expatriate new to the region needs to understand and take account of these challenges in planning and executing the project.

Leaders

Speakers

• Jeff Campie, USA
• Richard Forsyth, Senior Consultant, Hyde Engineering + Consulting, USA
• Nigel Hamilton, Global Quality, Strategy and Process Excellence, Sanofi Aventis, United Kingdom
• Aisling Horan, Validation Scientist, Alkermes Plc, Ireland
• Edwin Melendez, Principle Consultant, Parexel, USA
• Mark O'Reilly, Director Engineering, Alkermes Pharma Ireland Ltd, Ireland
• Kimberly Ray, A. Director Project Mgmt, Oso Biopharmaceuticals Mfg LLC, USA
• Julian Wilkins, Vice President, PharmaConsult US Inc, USA
• Paul Wreglesworth, Independent Consultant, United Kingdom

How You Will Benefit

• Understand the particular challenges of building a new facility in China
• Recognize cultural differences related to building in China as opposed to building in Europe or North America

Who Should Attend

Project Managers, Project Controllers, Cost Estimators, Schedulers, and Business Sponsors

Communities of Practice (COPs)

This session is of particular interest to existing and future members of the following ISPE Communities of Practice (COPs):

Project Management